Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women
- PMID: 20731864
- PMCID: PMC2936898
- DOI: 10.1186/1471-2334-10-249
Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women
Abstract
Background: Menstrual Toxic Shock Syndrome (mTSS) is thought to be associated with the vaginal colonization with specific strains of Staphylococcus aureus TSST-1 in women who lack sufficient antibody titers to this toxin. There are no published studies that examine the seroconversion in women with various colonization patterns of this organism. Thus, the aim of this study was to evaluate the persistence of Staphylococcus aureus colonization at three body sites (vagina, nares, and anus) and serum antibody to toxic shock syndrome toxin-producing Staphylococcus aureus among a small group of healthy, menstruating women evaluated previously in a larger study.
Methods: One year after the completion of that study, 311 subjects were recalled into 5 groups. Four samples were obtained from each participant at several visits over an additional 6-11 month period: 1) an anterior nares swab; 2) an anal swab; 3) a vagina swab; and 4) a blood sample. Gram stain, a catalase test, and a rapid S. aureus-specific latex agglutination test were performed to phenotypically identify S. aureus from sample swabs. A competitive ELISA was used to quantify TSST-1 production. Human TSST-1 IgG antibodies were determined from the blood samples using a sandwich ELISA method.
Results: We found only 41% of toxigenic S. aureus and 35.5% of non-toxigenic nasal carriage could be classified as persistent. None of the toxigenic S. aureus vaginal or anal carriage could be classified as persistent. Despite the low persistence of S. aureus colonization, subjects colonized with a toxigenic strain were found to display distributions of antibody titers skewed toward higher titers than other subjects. Seven percent (5/75) of subjects became seropositive during recall, but none experienced toxic shock syndrome-like symptoms.
Conclusions: Nasal carriage of S. aureus appears to be persistent and the best predicator of subsequent colonization, whereas vaginal and anal carriage appear to be more transient. From these findings, it appears that antibody titers in women found to be colonized with toxigenic S. aureus remained skewed toward higher titers whether or not the colonies were found to be persistent or transient in nature. This suggests that colonization at some point in time is sufficient to elevate antibody titer levels and those levels appear to be persistent. Results also indicate that women can become seropositive without experiencing signs or symptoms of toxic shock syndrome.
Figures


Similar articles
-
Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.J Clin Microbiol. 2005 Sep;43(9):4628-34. doi: 10.1128/JCM.43.9.4628-4634.2005. J Clin Microbiol. 2005. PMID: 16145118 Free PMC article.
-
Prevalence of toxic shock syndrome toxin 1 (TSST-1)-producing strains of Staphylococcus aureus and antibody to TSST-1 among healthy Japanese women.J Clin Microbiol. 2008 Aug;46(8):2731-8. doi: 10.1128/JCM.00228-08. Epub 2008 Jun 11. J Clin Microbiol. 2008. PMID: 18550735 Free PMC article.
-
Toxic shock syndrome toxin-1 (TSST-1) production and phage susceptibility of Staphylococcus aureus strains from human vaginas and anterior nares in Trinidad.Zentralbl Bakteriol. 1994 Jan;280(3):371-81. doi: 10.1016/s0934-8840(11)80599-2. Zentralbl Bakteriol. 1994. PMID: 8167431
-
Epidemiology of toxic shock syndrome toxin-1 harboring Staphylococcus aureus obtained from clinical samples in Iran: A Systematic Review and Meta-analysis.Ann Ig. 2018 Sep-Oct;30(5):391-400. doi: 10.7416/ai.2018.2239. Ann Ig. 2018. PMID: 30062367
-
Menstrual toxic shock syndrome: case report and systematic review of the literature.Lancet Infect Dis. 2019 Sep;19(9):e313-e321. doi: 10.1016/S1473-3099(19)30041-6. Epub 2019 May 28. Lancet Infect Dis. 2019. PMID: 31151811
Cited by
-
Development of in vitro methods to model the impact of vaginal lactobacilli on Staphylococcus aureus biofilm formation on menstrual cups as well as validation of recommended cleaning directions.Front Reprod Health. 2023 Aug 21;5:1162746. doi: 10.3389/frph.2023.1162746. eCollection 2023. Front Reprod Health. 2023. PMID: 37671283 Free PMC article.
-
Vaginal toxic shock reaction triggering desquamative inflammatory vaginitis.J Low Genit Tract Dis. 2013 Jan;17(1):88-91. doi: 10.1097/LGT.0b013e3182656991. J Low Genit Tract Dis. 2013. PMID: 23222054 Free PMC article.
-
Device-Associated Menstrual Toxic Shock Syndrome.Clin Microbiol Rev. 2020 May 27;33(3):e00032-19. doi: 10.1128/CMR.00032-19. Print 2020 Jun 17. Clin Microbiol Rev. 2020. PMID: 32461307 Free PMC article. Review.
-
Suppression of starvation-induced autophagy by recombinant toxic shock syndrome toxin-1 in epithelial cells.PLoS One. 2014 Nov 17;9(11):e113018. doi: 10.1371/journal.pone.0113018. eCollection 2014. PLoS One. 2014. PMID: 25402468 Free PMC article.
-
Teenage boy with high fever and rash: what could we be missing?BMJ Case Rep. 2018 Feb 8;2018:bcr2017223497. doi: 10.1136/bcr-2017-223497. BMJ Case Rep. 2018. PMID: 29437816 Free PMC article.
References
-
- Chesney PJ. Clinical aspects and spectrum of illness of toxic shock syndrome: overview. Rev Infect Dis. 1989;11(Suppl 1):S1–S7. - PubMed
-
- Gaventa S, Reingold AL, Hightower AW, Broome CV, Schwartz B, Hoppe C, Harwell J, Lefkowitz LK, Makintubee S, Cundiff DR, Sitze S. the Toxic Shock Syndrome Study Group. Active surveillance for toxic shock syndrome in the United States, 1986. Rev Infect Dis. 1989;11(Suppl 1):S28–S34. - PubMed
-
- Todd JK, Wisenthal AM, Ressman M, Caston SA, Hopkins RS. Toxic shock syndrome II. Estimated occurrence in Colorado as influenced by case ascertainment methods. Am J Epidemiol. 1985;122:857–867. - PubMed
-
- Descloux E, Perpoint T, Ferry T, Lina G, Bes M, Vandenesch F, Mohammedi I, Etienne J. One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases. Eur J Clin Microbiol Infect Dis. 2008;27(1):37–43. doi: 10.1007/s10096-007-0405-2. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical